Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients.

Hirsch D, Odorico J, Danobeitia JS, Alejandro R, Rickels MR, Hanson M, Radke N, Baidal D, Hullett D, Naji A, Ricordi C, Kaufman D, Fernandez L.

Am J Transplant. 2012 May;12(5):1275-89. doi: 10.1111/j.1600-6143.2011.03947.x. Epub 2012 Feb 2.

2.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
3.

Early metabolic markers of islet allograft dysfunction.

Baidal DA, Faradji RN, Messinger S, Froud T, Monroy K, Ricordi C, Alejandro R.

Transplantation. 2009 Mar 15;87(5):689-97. doi: 10.1097/TP.0b013e318195c249.

4.

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM.

Diabetes. 2001 Apr;50(4):710-9.

5.

Long-term function (6 years) of islet allografts in type 1 diabetes.

Alejandro R, Lehmann R, Ricordi C, Kenyon NS, Angelico MC, Burke G, Esquenazi V, Nery J, Betancourt AE, Kong SS, Miller J, Mintz DH.

Diabetes. 1997 Dec;46(12):1983-9.

PMID:
9392484
6.

Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.

Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ.

Xenotransplantation. 2011 Nov-Dec;18(6):328-42. doi: 10.1111/j.1399-3089.2011.00676.x.

PMID:
22168140
7.

Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.

Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP.

Diabetes. 1998 Mar;47(3):324-30.

PMID:
9519735
8.

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV.

N Engl J Med. 2000 Jul 27;343(4):230-8.

9.

Primary graft function, metabolic control, and graft survival after islet transplantation.

Vantyghem MC, Kerr-Conte J, Arnalsteen L, Sergent G, Defrance F, Gmyr V, Declerck N, Raverdy V, Vandewalle B, Pigny P, Noel C, Pattou F.

Diabetes Care. 2009 Aug;32(8):1473-8. doi: 10.2337/dc08-1685.

10.

Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.

Warnock GL, Meloche RM, Thompson D, Shapiro RJ, Fung M, Ao Z, Ho S, He Z, Dai LJ, Young L, Blackburn L, Kozak S, Kim PT, Al-Adra D, Johnson JD, Liao YH, Elliott T, Verchere CB.

Arch Surg. 2005 Aug;140(8):735-44.

PMID:
16103282
11.

Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.

Soleimanpour SA, Hirshberg B, Bunnell DJ, Sumner AE, Ader M, Remaley AT, Rother KI, Rickels MR, Harlan DM.

Cell Transplant. 2012;21(6):1297-304. doi: 10.3727/096368911X603620. Epub 2011 Nov 11.

12.
13.

Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.

Barshes NR, Lee T, Goodpasture S, Brunicardi FC, Alejandro R, Ricordi C, Soltes G, Barth M, Hamilton D, Goss JA.

Transplant Proc. 2004 May;36(4):1127-9.

PMID:
15194393
14.

Successful islet transplantation: continued insulin reserve provides long-term glycemic control.

Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM.

Diabetes. 2002 Jul;51(7):2148-57.

15.

Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation.

Cretin N, Caulfield A, Fournier B, B├╝hler L, Becker C, Philippe J, Morel P.

Transpl Int. 2001 Sep;14(5):343-5.

16.

Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.

Contreras JL, Eckhoff DE, Cartner S, Bilbao G, Ricordi C, Neville DM Jr, Thomas FT, Thomas JM.

Transplantation. 2000 Jan 27;69(2):195-201.

PMID:
10670626
17.

The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.

Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM, Cure PE, Monroy K, Mendez A, Selvaggi G, Ricordi C, Alejandro R.

Transplantation. 2008 Jul 15;86(1):36-45. doi: 10.1097/TP.0b013e31817c4ab3.

18.

Five-year follow-up after clinical islet transplantation.

Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM.

Diabetes. 2005 Jul;54(7):2060-9.

19.

Transaminitis after pancreatic islet transplantation.

Barshes NR, Lee TC, Goodpastor SE, Balkrishnan R, Schock AP, Mote A, Brunicardi FC, Alejandro R, Ricordi C, Goss JA.

J Am Coll Surg. 2005 Mar;200(3):353-61.

PMID:
15737845
20.

{beta}-Cell function following human islet transplantation for type 1 diabetes.

Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL.

Diabetes. 2005 Jan;54(1):100-6.

Supplemental Content

Support Center